Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.
Vaugier L, Ah-Thiane L, Aumont M, Jouglar E, Campone M, Colliard C, Doucet L, Frenel JS, Gourmelon C, Robert M, Martin SA, Riem T, Roualdes V, Campion L, Mervoyer A. Vaugier L, et al. Among authors: aumont m. Sci Rep. 2021 Nov 11;11(1):22057. doi: 10.1038/s41598-021-01537-3. Sci Rep. 2021. PMID: 34764361 Free PMC article.
Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma.
Doucet L, Cailleteau A, Vaugier L, Gourmelon C, Bureau M, Salaud C, Roualdes V, Samarut E, Aumont M, Zenatri M, Loussouarn D, Quillien V, Bocquet F, Payen-Gay L, Joubert D, Prieur A, Robert M, Frenel JS. Doucet L, et al. Among authors: aumont m. ESMO Open. 2023 Oct;8(5):101626. doi: 10.1016/j.esmoop.2023.101626. Epub 2023 Sep 13. ESMO Open. 2023. PMID: 37713930 Free PMC article.
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.
Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, Aumont M, Thillays F, Sunyach MP, Henzen C, Missohou F, de Crevoisier R, Bondiau PY, Collin P, Durando X, Truc G, Kerr C, Bernier V, Clavier JB, Atlani D, D'Hombres A, Vinchon-Petit S, Lagrange JL, Taillandier L. Noel G, et al. Among authors: aumont m. J Neurooncol. 2012 Aug;109(1):167-75. doi: 10.1007/s11060-012-0883-7. Epub 2012 Jun 2. J Neurooncol. 2012. PMID: 22660920
Severe radiotherapy-induced extracutaneous toxicity under vemurafenib.
Peuvrel L, Ruellan AL, Thillays F, Quereux G, Brocard A, Saint-Jean M, Aumont M, Drouet F, Dreno B. Peuvrel L, et al. Among authors: aumont m. Eur J Dermatol. 2013 Nov-Dec;23(6):879-81. doi: 10.1684/ejd.2013.2193. Eur J Dermatol. 2013. PMID: 24192487
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
de la Rochefordiere A, Kamal M, Floquet A, Thomas L, Petrow P, Petit T, Pop M, Fabbro M, Kerr C, Joly F, Sevin E, Maillard S, Curé H, Weber B, Brunaud C, Minsat M, Gonzague L, Berton-Rigaud D, Aumont M, Gladieff L, Peignaux K, Bernard V, Leroy Q, Bieche I, Margogne A, Nadan A, Fourchotte V, Diallo A, Asselain B, Plancher C, Armanet S, Beuzeboc P, Scholl SM. de la Rochefordiere A, et al. Among authors: aumont m. Clin Cancer Res. 2015 Jun 1;21(11):2530-7. doi: 10.1158/1078-0432.CCR-14-2368. Epub 2015 Feb 27. Clin Cancer Res. 2015. PMID: 25724520 Clinical Trial.
Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study.
Rogé M, Salleron J, Kirova Y, Guigo M, Cailleteau A, Levy C, Leheurteur M, Nebbache R, Rivin Del Campo E, Lazarescu I, Servagi S, Aumont M, Thariat J, Thureau S. Rogé M, et al. Among authors: aumont m. Cancers (Basel). 2022 Aug 15;14(16):3928. doi: 10.3390/cancers14163928. Cancers (Basel). 2022. PMID: 36010921 Free PMC article.
119 results